Michael F. Weaver

Michael F. Weaver

Psychiatry

1941 East Rd
Ste 2100
Houston, TX 77054

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.

Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trial.

Journal: BMJ open

Published: May 20, 2026

A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol.

A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol.

Journal: Contemporary clinical trials

Published: February 10, 2025

E-cigarettes and Youth: The Known, the Unknown, and Implications for Stakeholders.

E-cigarettes and Youth: The Known, the Unknown, and Implications for Stakeholders.

Journal: Journal of addiction medicine

Published: March 18, 2024

Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART).

Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART).

Journal: Drug and alcohol dependence

Published: October 14, 2023

Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study.

Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study.

Journal: Journal of addiction medicine

Published: August 14, 2023

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial.

Journal: BMJ open

Published: June 14, 2023

Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.

Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.

Journal: Journal of substance use and addiction treatment

Published: September 19, 2022

Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States.

Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States.

Journal: Drug and alcohol dependence

Published: May 14, 2021

Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial.

Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial.

Journal: Contemporary clinical trials

Published: April 10, 2021

Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment.

Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment.

Journal: Journal of psychopharmacology (Oxford, England)

Published: February 15, 2021

Cannabis use: A co-existing condition in first-episode bipolar mania patients.

Cannabis use: A co-existing condition in first-episode bipolar mania patients.

Journal: Journal of affective disorders

Published: July 31, 2019

Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder.

Journal: Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors

Published: June 25, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026